Etelcalcetide versus placebo for secondary hyperparathyroidism in patients receiving hemodialysis: A meta-analysis of randomized controlled trials
2019 ◽
Vol 51
(11)
◽
pp. 2027-2036
Keyword(s):
Keyword(s):